Naltrexona Amomed (Naltrexone Hydrochloride)

Naltrexone acts as a competitive antagonist at the mu, kappa and delta opioid receptors. By binding to these receptors without activating them, it prevents endogenous and exogenous opioids from producing their usual effects, thereby decreasing reinforcement, craving, and the rewarding sensations associated with alcohol and opioid use.

The specific dose and dosing schedule of Naltrexona Amomed are determined by the prescribing clinician based on the individual’s medical condition, treatment goals, and response to therapy. Healthcare providers follow local guidelines and adjust the regimen as needed.

Safety data for naltrexone in pregnancy and lactation are limited. Because potential risks cannot be ruled out, the drug is generally avoided unless the potential benefit justifies the possible harm to the fetus or infant. Consultation with a healthcare professional is essential.

To request Naltrexona Amomed, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

For alcohol dependence, alternatives such as acamprosate or disulfiram have different mechanisms; naltrexone targets opioid receptors to reduce craving, whereas acamprosate modulates glutamate and GABA pathways. In opioid dependence, methadone and buprenorphine are agonist‑based maintenance therapies, while naltrexone is an antagonist that blocks opioid effects after detoxification.

Store Naltrexona Amomed at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Naltrexona Amomed is taken orally, usually with a full glass of water. The tablet should be swallowed whole and not chewed or crushed. Administration is typically performed under medical supervision, especially during the initial phase of treatment.

Serious adverse events include hepatotoxicity, severe allergic reactions such as anaphylaxis, and the emergence of depression or suicidal thoughts. Patients should report any signs of liver dysfunction, rash, breathing difficulty, or mood changes to their healthcare provider immediately.

Naltrexona Amomed is contraindicated in individuals with a known hypersensitivity to naltrexone or any excipients, in patients currently undergoing acute opioid withdrawal, and in those with severe hepatic impairment. Caution is also advised for patients with renal dysfunction or uncontrolled psychiatric illness.